Nurse Practitioner, Family · Zanesville, OH
NPI
1982190260
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
945 Bethesda Dr Ste 230
Zanesville, OH, 43701
Phone (740) 586-6888
Groups this clinician bills Medicare through
Medicare paid, 2024
$21K
401 services
Medicare patients, 2024
225
Average age 72
Drug cost, 2024
$1.5M
5,576 prescriptions
Company payments, 2025
$193
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gretchen S Rossiter was code 99214 (office e&m - established), 334 times for 213 patients. In total Gretchen S Rossiter billed 401 services in 7 codes, and Medicare paid $21K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 334 | 213 | $55.32 | $18K |
| 99406 Behavioral Health Services | Facility | 34 | 28 | $9.55 | $325 |
| 99213 Office E&M - Established | Facility | 16 | 16 | $35.73 | $572 |
By year: 2022 $17K for 401 services; 2023 $23K for 450 services; 2024 $21K for 401 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gretchen S Rossiter prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,073 prescriptions and refills. In total Gretchen S Rossiter wrote 5,576 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,073 | 1,153 | 287 | $38K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 485 | 534 | 92 | $340K |
| Ventolin Hfa Albuterol Sulfate | 373 | 378 | 93 | $19K |
| Spiriva Respimat Tiotropium Bromide | 364 | 388 | 71 | $198K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 310 | 336 | 61 | $153K |
| Prednisone Generic | 304 | 304 | 179 | $628 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 216 | 222 | 44 | $138K |
| Symbicort Budesonide/Formoterol Fumarate | 194 | 208 | 44 | $44K |
| Incruse Ellipta Umeclidinium Bromide | 185 | 198 | 35 | $67K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 185 | 195 | 33 | $90K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 184 | 195 | 41 | $31K |
| Advair Hfa Fluticasone Propion/Salmeterol | 130 | 148 | 23 | $52K |
| Montelukast Sodium Generic | 121 | 196 | 26 | $518 |
| Breo Ellipta Fluticasone/Vilanterol | 116 | 124 | 19 | $49K |
| Arnuity Ellipta Fluticasone Furoate | 109 | 134 | 22 | $31K |
Brand drugs: 4,283 claims; generic drugs: 1,293 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gretchen S Rossiter $193 ($193 in general payments such as food, travel and fees) from 9 companies. The largest payer was Pulmonx Corporation with $42.66.
| Company | Payments | Amount |
|---|---|---|
| Pulmonx Corporation LUNG | 1 | $42.66 |
| GlaxoSmithKline, LLC. GSK | 2 | $31.04 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $18.88 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $17.83 |
| Vifor Pharma, Inc. | 1 | $17.81 |
| Insmed, Inc. INSM | 1 | $17.77 |
| Verona Pharma, Inc. VRNA | 1 | $16.32 |
| Amgen Inc. AMGN | 1 | $16.14 |
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $14.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.